94
Participants
Start Date
December 14, 2017
Primary Completion Date
February 2, 2018
Study Completion Date
August 9, 2018
HSK3486
HSK3486 intravenous (iv) 0.4(0.5) mg/kg for induction, and 0.2 (0.15)mg/kg top-ups for maintenance. 0.3(0.375) mg/kg for induction and 0.15 (0.113)mg/kg for maintenance in adults of 65-70 years old
Propofol
Propofol iv 2.0 mg/kg for induction, and 1.0 mg/kg top-ups for maintenance. 1.5 mg/kg for induction and 0.75mg/kg for maintenance in adults of 65-70 years old.
West China Hospital, Sichuan University, Changde
The Second Xiangya Hospital of Central South University, Changsha
The Third Xiangya Hospital of Central South University, Changsha
Sichuan Provincial People's Hospital, Chengdu
Shanghai Fengxian District Central Hospital, Shanghai
The second Affiliated Hospital of Wenzhou Medical University, Wenzhou
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
General Hospital of Ningxia Medical University, Yinchuan
Sichuan Haisco Pharmaceutical Group Co., Ltd
INDUSTRY